SSTAR of Rhode Island SSTARBirth

SSTAR of Rhode Island SSTARBirth, based in Cranston, RI, is one of the SAMHSA-registered treatment programs operating in RI. The facility offers specific levels of care: Inpatient, MAT. What this page can help with is the frame — what to ask, what to verify, what to compare against.

Care levels at SSTAR of Rhode Island SSTARBirth

The care-level question matters because what a facility offers is what it can realistically treat well. The facility's documented care levels are The facility offers specific levels of care: Inpatient, MAT. — each of which is appropriate for specific clinical presentations. Matching the level to the specific clinical need is the pre-admission work. Before admission, an independent clinical assessment (from a primary-care doctor, licensed substance-use counselor, or addiction-medicine physician) can confirm whether SSTAR of Rhode Island SSTARBirth's offerings match the clinical need.

Insurance and payment

SSTAR of Rhode Island SSTARBirth accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The single most useful pre-admission move on insurance is requesting the facility send you — in writing, by email — the specific benefits verification for your specific plan product. That document is the answer to most post-admission billing disputes.

Specialty programming

The facility's documented specialty programming includes: Adult women, Pregnant/postpartum women, Clients with co-occurring mental and substance use disorders. The specialty question rewards specific follow-up: what clinicians provide the specialty content, what their credentials are, what percentage of weekly programming is specialty-specific vs. general programming.

Before you call

Three questions to put to SSTAR of Rhode Island SSTARBirth before admission: the specific ASAM level the facility is billing; the written Verification of Benefits for your specific plan product; the MAT policy (continuation of buprenorphine or methadone during residential, specifically). The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation. Getting answers in writing protects against the downstream surprises.